<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A set of stable mouse-human hybrids was constructed from the neoplastic lymphocytes from a patient with nodular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and from another with <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Both patients had shown a clinical response to human leucocyte interferon </plain></SENT>
<SENT sid="2" pm="."><plain>The same interferon preparation inhibited the growth rate of 14 out of 17 established hybrid cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>This system provides evidence of a direct growth inhibitory effect of interferon on neoplastic B lymphocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Such a system could be used to predict the sensitivity of a patient's <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> before therapy </plain></SENT>
</text></document>